MONODAC Trademark

Trademark Overview

On Monday, July 13, 2020, a trademark application was filed for MONODAC with the United States Patent and Trademark Office. The USPTO has given the MONODAC trademark a serial number of 90049843. The federal status of this trademark filing is REGISTERED as of Tuesday, August 13, 2024. This trademark is owned by C4 Therapeutics, Inc.. The MONODAC trademark is filed in the Pharmaceutical Products category with the following description:

Protein degraders for the prevention and treatment of human diseases and conditions, namely, cancer, tumors, neurological diseases and disorders, hematological diseases and disorders, pharmaceutical products for the prevention and treatment of cancer, tumors, neurological, pharmaceutical preparations for immunotherapy
monodac

General Information

Serial Number90049843
Word MarkMONODAC
Filing DateMonday, July 13, 2020
Status700 - REGISTERED
Status DateTuesday, August 13, 2024
Registration Number7475373
Registration DateTuesday, August 13, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements

Goods and ServicesProtein degraders for the prevention and treatment of human diseases and conditions, namely, cancer, tumors, neurological diseases and disorders, hematological diseases and disorders, pharmaceutical products for the prevention and treatment of cancer, tumors, neurological, pharmaceutical preparations for immunotherapy
Pseudo MarkMONO DAC

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 10, 2020
Primary Code005
First Use Anywhere DateTuesday, October 31, 2023
First Use In Commerce DateTuesday, October 31, 2023

Trademark Owner History

Party NameC4 Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameC4 Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameC4 Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Saturday, October 24, 2020NON-FINAL ACTION E-MAILED
Monday, August 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 22, 2020ASSIGNED TO EXAMINER
Saturday, October 24, 2020NON-FINAL ACTION WRITTEN
Saturday, October 24, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 19, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 8, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 3, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 1, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 1, 2022SOU EXTENSION 1 FILED
Tuesday, February 1, 2022SOU EXTENSION 1 GRANTED
Thursday, February 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 1, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 1, 2022SOU EXTENSION 2 FILED
Monday, August 1, 2022SOU EXTENSION 2 GRANTED
Wednesday, August 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2023SOU TEAS EXTENSION RECEIVED
Monday, January 30, 2023SOU EXTENSION 3 FILED
Monday, January 30, 2023SOU EXTENSION 3 GRANTED
Wednesday, February 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 27, 2023SOU EXTENSION 4 FILED
Tuesday, June 27, 2023SOU EXTENSION 4 GRANTED
Thursday, June 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2023USE AMENDMENT FILED
Wednesday, December 13, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 13, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, December 13, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, December 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 21, 2024ASSIGNED TO LIE
Wednesday, July 10, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 10, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 13, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

monodac diseases tumors neurological disorders pharmaceutical cancer treatment prevention products preparations